Essity


A well-balanced health and hygiene proposition

08/01/19 -"Recommendation and upside We are initiating coverage of Essity (market cap: SEK152bn/€15bn and free float: 91%) with an ‘Add’ recommendation and a target price of SEK229 per share (5.5% upside). Our ..."

Pages
43
Language
English
Published on
08/01/19
You may also be interested by these reports :
17/01/19
Beiersdorf reported a small set of top-line figures for FY 2018. Group sales rose +2.5% to €7,233m, driven by +5.4% organic growth, and meeting ...

08/01/19
Recommendation and upside We are initiating coverage of Essity (market cap: SEK152bn/€15bn and free float: 91%) with an ‘Add’ recommendation and a ...

14/12/18
We have reduced our EV/EBIT multiples from 11x for Asia and 10x for other regions to 9x for all business areas. This adjustment was applied to ...

15/11/18
Henkel reported slowing organic growth rates qoq, especially in Adhesive Technologies. Sales price increases were the strongest in the current year ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO